This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: American Cyanamid Company. Active years: 1993-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1997
Title: The Innovative Contributions of Nancy S. Brizzolara
Introduction
Nancy S. Brizzolara is a notable inventor based in Congers, NY (US). She has made significant contributions to the field of dental health through her innovative inventions. With a total of 3 patents, her work focuses on the treatment of periodontal disease.
Latest Patents
Brizzolara's latest patents include a method for the treatment of periodontal disease by sustained delivery of oral compositions. These compositions are designed for the local administration of a therapeutic agent to a periodontal pocket of a patient. The invention comprises a plurality of dry, discrete microparticles, each containing an effective amount of at least one therapeutic agent dispersed in a biocompatible and biodegradable polymer matrix. The apparatus and methods provided allow for the dispensing of these dry microparticles to the periodontal pocket, where they become tacky and adhere to the involved tissue, inducing long-term therapeutic benefits.
Career Highlights
Nancy S. Brizzolara has worked with the American Cyanamid Company, where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to advancements in dental treatments, showcasing her commitment to improving patient care.
Collaborations
Throughout her career, Brizzolara has collaborated with notable coworkers, including Michael G. Lanzilotti and James R. Lawter. These collaborations have further enhanced her research and development efforts in the field of dental health.
Conclusion
Nancy S. Brizzolara's contributions to dental health through her innovative patents demonstrate her dedication to improving treatment options for periodontal disease. Her work continues to influence the field and offers promising solutions for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile